Company: PTPI
Filing Date: 2025-02-13
Form Type: S-1/A
Source: 0001410578-25-000122
Chunk: 250

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-13
Form: S-1/A
Chunk 250
---
 
 Redeemable  
 Preferred   
 Stock       
 Amount      
 ​           |          ​ 
          ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ |          ​ 
          ​ 
          ​ 
          ​ 
     Common 
      Stock 
          ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​      
 ​      
 ​      
 Common 
 Stock  
 Amount 
 ​      |     ​ 
     ​ 
     ​ 
     ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​          
 ​          
 ​          
 Additional 
 Paid-in    
 Capital    
 ​          |           ​ 
           ​ 
           ​ 
           ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​           
 ​           
 ​           
 ​           
 Accumulated 
 Deficit     
 ​           |            ​ 
            ​ 
            ​ 
            ​ 
            ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​     
 ​     
 ​     
 ​     
 ​     
 Total 
 ​     |          ​ 
          ​ 
          ​ 
          ​ 
          ​ 
          ​ |
|:--------------------------------------------------|:--|------------:|:--|:------------|-----------:|:--|:--|-----------:|:--|:-------|------:|:--|:-----------|------------:|:--|:------------|-------------:|:--|:------|-----------:|
| Balance, June 30, 2024                            | ​ |       4,039 | ​ | $           |  1,115,762 | ​ | ​ |  9,297,538 | ​ | $      |   930 | ​ | $          | 109,783,623 | ​ | $           | -101,714,270 | ​ | $     |  8,070,283 |
| Stock-based compensation expense                  | ​ |           — | ​ | ​           |          — | ​ | ​ |          — | ​ | ​      |     — | ​ | ​          |           — | ​ | ​           |            — | ​ | ​     |          — |
| Common Stock issued for services                  | ​ |           — | ​ | ​           |          — | ​ | ​ |    136,986 | ​ | ​      |    14 | ​ | ​          |      59,986 | ​ | ​           |            — | ​ | ​     |     60,000 |
| Series